Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Cecropia leaves (C. obtusifolia, C. pachystachya, C. peltata) are rich in chlorogenic acid, orientin, and isoorientin—flavone C-glycosides that inhibit α-glucosidase enzymes and modulate NF-κB-mediated inflammatory pathways, with a clinical trial in type 2 diabetics demonstrating significant reductions in blood glucose and serum lipids (PMID 15636168). Multivariate phytochemical analyses have identified these polyphenols as reliable chemical markers across Cecropia species, supporting their standardized use for antidiabetic, antioxidant, and anti-inflammatory applications (PMID 28372473; PMID 30742130).
Reported Benefits (Provisional)
Origin & History
Cecropia (Cecropia peltata) is a fast-growing tropical tree native to the rainforests of Central and South America, particularly thriving in the Amazon Basin, Andes, and cloud forests of Colombia, Ecuador, and Brazil. Its large, heart-shaped leaves are distinctive, deeply veined, and flourish in humid, lowland regions along riverbanks. Revered in traditional Amazonian medicine, Cecropia leaf is valued for its functional properties that support cardiovascular, respiratory, and metabolic health.
Research Narrative (Provisional)
A clinical trial by Herrera-Arellano et al. (2004) in Phytomedicine evaluated Cecropia obtusifolia leaf extract in type 2 diabetic patients and reported significant reductions in fasting blood glucose and improved serum lipid profiles compared to baseline (PMID 15636168). Rivera-Mondragón et al. (2017, 2019) used HPLC-DAD-MS/MS and multivariate analysis across four Cecropia species collected in Panama to establish chlorogenic acid, orientin, isoorientin, and isovitexin as principal chemical markers for quality control (PMID 28372473; PMID 30742130). Bona et al. (2024) in Molecular Neurobiology demonstrated that Cecropia pachystachya leaf extract exhibited antitumoral activity against rat glioma cells both in vitro and in vivo, reducing tumor volume and modulating oxidative stress markers in brain tissue (PMID 38483655). Mendonça et al. (2016) in the Journal of Ethnopharmacology showed that aqueous extracts of C. pachystachya possess antigenotoxic effects in vivo while exhibiting no significant mutagenic activity at tested concentrations, supporting a favorable safety profile (PMID 27435375).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals: Flavonoids, polyphenols, saponins, tannins, alkaloids, terpenoids, plant sterols, glycosides. - Vitamins: Vitamin A, Vitamin C, Vitamin E. - Minerals: Potassium, Magnesium, Calcium.
Reported Mechanism (Provisional)
The primary antidiabetic mechanism involves competitive inhibition of intestinal α-glucosidase by the flavone C-glycosides isoorientin and orientin, which bind the enzyme's active site and reduce postprandial glucose absorption, as supported by clinical outcomes in type 2 diabetics (PMID 15636168). Chlorogenic acid concurrently activates AMPK signaling and suppresses NF-κB nuclear translocation, downregulating proinflammatory cytokines IL-1β, IL-12p40, and TNF-α in macrophages and endothelial cells. The antitumoral effects observed in glioma models (PMID 38483655) are attributed to ursolic acid and polyphenol-mediated induction of apoptosis via caspase-3 activation and modulation of oxidative stress enzymes including superoxide dismutase and catalase. Additionally, isovitexin and chlorogenic acid scavenge reactive oxygen species directly, protecting cellular lipids and DNA from oxidative damage, consistent with the antigenotoxic findings of Mendonça et al. (PMID 27435375).
Clinical Narrative (Provisional)
Current evidence is predominantly preclinical, with limited human clinical trials available. Animal studies in mice demonstrated 33.3-35.7% plasma glucose reduction using methanolic leaf extracts, while guinea pig bronchospasm studies showed 5-fold increases in histamine tolerance thresholds. In vitro studies revealed α-glycosidase inhibition with IC₅₀ of 14 μg/mL, superior to acarbose, and up to 40% inhibition of lipopolysaccharide-stimulated nitric oxide production in macrophages. The single human study available showed 3-4% lung capacity improvement with C. obtusifolia decoction, but robust clinical trial data remains insufficient to establish definitive therapeutic dosing and efficacy.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.